Ligand profile
ZINC9331545
Virtual-screening candidate from ZINC.
Bound to: VK055_1238 — exodeoxyribonuclease III
Identifiers
Database identifiers and provenance.
- Ligand ID
ZINC9331545- UniProt (similar protein)
P27695- Tanimoto
- 0.960
- Target protein
- VK055_1238
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 29.1
- −1 ≤ LogP ≤ 5 2.74
- MW ≤ 500 Da 227.4
- LogP ≤ 5 2.74
- H-bond donors ≤ 5 1
- H-bond acceptors ≤ 10 3
- Rotatable bonds ≤ 10 0
- TPSA ≤ 140 Ų 29.1
Matches PAINS filter: ene_rhod_A(235). May be a frequent false positive in HTS — review carefully.
Chemical representations
Canonical representations for cheminformatics workflows.
O=C1NC(=S)SC1=C1CCCCCC1O=C1NC(=S)SC1=C1CCCCCC1
InChI=1S/C10H13NOS2/c12-9-8(14-10(13)11-9)7-5-3-1-2-4-6-7/h1-6H2,(H,11,12,13)InChI=1S/C10H13NOS2/c12-9-8(14-10(13)11-9)7-5-3-1-2-4-6-7/h1-6H2,(H,11,12,13)
LBNZBMZVSDLBMK-UHFFFAOYSA-NLBNZBMZVSDLBMK-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Query
- CHEMBL1478395
- Homolog
- P27695
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ZINC ZINC15 ZINC9331545 →
- ZINC ZINC20 ZINC9331545 →
- UniProt UniProt P27695 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “ZINC9331545”) →
Other ligands for this protein
Quick navigation to other ligands bound to VK055_1238.
ChEMBL 100
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 49
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).